Catalyst of Exchanges and Source of Progress
ELI stems from innovative research, and the thought given to this area has led to the creation of the first network of exchanges, collaboration and European coordination dedicated to lymphoma.
Such cross-functional European collaboration shall help improve knowledge, the sharing of successful experiences and offer all patients equally effective care.
The studies conducted on the initiative of ELI will also contribute to harmonising regulatory texts on clinical research within the European Union.
The ELI model is broadly inspired by the operating principles used within LYSA – The Lymphoma Study Association
– A group of first-rate European scientific experts leading research strategies, the research topics are determined by way of workshops that regroup approximately 50 specialists. The objectives of these workshops are to analyse the subject, identify the issues to be resolved and set up collaborative action plans.
– Operational structures organise and steer clinical trials according to the therapeutic solutions proposed and the teams involved.